Company Monitoring Page for Biodel

latest headlines for company on cafepharma

Biodel's insulin drug found effective in trial
Yahoo/Reuters
Mon, 08/11/14 - 08:01 am
Tags:
Biodel, insulin, diabetes, BIOD-531
Eight Biotech Stocks Trading Near $5 With Huge Upside Potential
24/7 Wall St
Fri, 02/7/14 - 09:43 am
Tags:
Array Biopharma, Biodel, Galena Biopharma, Novavax, Protalix BioTherapeutics, Rigel Pharmaceuticals, Synta Pharmaceuticals, Zogenix
Biodel Inc: Strong Biotech 'January Effect' Candidate For 2014
Seeking Alpha
Thu, 01/2/14 - 11:07 am
Tags:
Biodel, insulin, diabetes
Biodel up 10.5 percent premarket after supply agreement with Becton Dickinson
Reuters
Tue, 12/17/13 - 09:35 am
Tags:
Biodel, Becton Dickinson
Biodel: Creating A Better, Faster Acting Insulin, The Next Big Thing For Diabetic Therapy
Seeking Alpha
Thu, 09/12/13 - 11:39 am
Tags:
Biodel, insulin, diabetes, BIOD-123
Biodel's BIOD-123 Achieves Primary Endpoint in Phase 2 Clinical Trial Demonstrating Glycemic Control Comparable to Humalog(R)
Yahoo
Mon, 09/9/13 - 09:52 am
Tags:
Biodel, BIOD-123, clinical trials, diabetes, type 1 diabetes
Is This a MannKind Killer?
Motley Fool
Tue, 09/3/13 - 09:54 am
Tags:
MannKind, diabetes, Afrezza, BIOD-123, insulin, Biodel
[video] Biotech's Next Big Thing: Fall Trials
TheStreet.com
Fri, 08/23/13 - 10:20 am
Tags:
clinical trials, Biodel, Coronado Biosciences, Achillion, BIOD-531, hepatitis C, pig whip worms
Our BioPharma Catalyst Watch List
Seeking Alpha
Thu, 08/15/13 - 12:09 pm
Tags:
Astex, Biodel, Insmed, MannKind, Onconova, Afrezza, Dacogen, Arikace, Rigosertib
Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Seeking Alpha
Tue, 08/6/13 - 10:00 am
Tags:
GLP-1 agonist, diabetes, Oramed, Biodel, Bristol-Myers Squibb, Eli Lilly, MannKind, Novo Nordisk, Merck, Afrezza, Januvia, Victoza
Why Biodel Will Have Positive Phase II Results
Seeking Alpha
Wed, 07/31/13 - 09:20 am
Tags:
Biodel, BIOD-123, type 1 diabetes, type 2 diabetes, diabetes
BioPharma Catalyst Trade Pick Of The Week: Biodel
Seeking Alpha
Tue, 07/30/13 - 11:43 am
Tags:
MannKind, Eli Lilly, Biodel, Astex
3 Biotech Catalysts Primed To Be Successful In Q3
Seeking Alpha
Wed, 07/24/13 - 09:48 am
Tags:
BIOD-123, Biodel, MannKind, Afrezza, GTx
Unilife: Taking Positions Ahead Of A Key Fiscal Year
Seeking Alpha
Thu, 07/18/13 - 09:32 am
Tags:
Unilife, Biodel
Biodel: A Biotech Company Weathering The Volatility
Seeking Alpha
Wed, 06/26/13 - 09:44 am
Tags:
Biodel
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:07 am
Tags:
Zerenex, Xoma, Vical, Takeda, sovaprevir, Soluble Ferric Pyrophosphate, Rockwell Medical, Orexigen, MM-398, Merrimack Pharmaceuticals, MannKind, Keryx, GTx, GSK, gevokizumab, enobosarm, Coronado Biosciences, Contrave, CNDO-201, clinical trials, ChemoCentryx, CCX140, Biodel, BIOD-123, Amigal, Amicus Therapeutics, Alnylam, ALN-TTR02, Allovectin, Afrezza, Achillion, ACH-3102
The Run-Up Trade: Biodel's Insulin Trial Results
TheStreet.com
Thu, 05/30/13 - 09:01 am
Tags:
insulin, diabetes, Biodel, BIOD-123, MannKind, Afrezza
Biodel: Reemerging From Obscurity In 2013
Seeking Alpha
Thu, 04/11/13 - 11:34 am
Tags:
Biodel, Eli Lilly, BIOD-123, recombinant human insulin, BIOD-250
Biodel's CEO Discusses F3Q12 Results - Earnings Call Transcript
Seeking Alpha
Fri, 08/10/12 - 06:34 pm
Tags:
Biodel, earnings
Biodel raises $18.5M in a private placement
The Fly on the Wall
Fri, 06/22/12 - 10:31 am
Tags:
Biodel

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.